Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Nuvation Bio Inc
NUVBCurrent price
2.63 USD
-0.25 USD (-8.68%)
Last closed
2.87 USD
Company
www.nuvationbio.com
ISIN
US67080N1019
Sector
Healthcare
Industry
Biotechnology
Exchange
NYSE
Capitalization
969 313 024 USD
Yield for 12 month
+100.76 %
1Y
3Y
5Y
10Y
15Y
NUVB
Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic candidates for oncology. The company's lead product candidate is NUV-868, a BD2 selective oral small molecule BET inhibitor that epigenetically regulates proteins that control tumor growth and differentiation, including oncogenes comprising c-myc; NUV-1156, an AR binder Xtandi that address advanced stage prostate cancers with the potential to move into earlier lines typically treated with surgical prostatectomy; and drug-drug conjugate (DDC) platform which leverages a novel therapeutic approach within the drug-conjugate class of anti-cancer therapies to deliver anti-cancer therapeutics to cancer cells, as well as NUV-1176, a PARP inhibitor to address ER+ breast and ovarian cancer. The company was founded in 2018 and is headquartered in New York, New York. Address: 1500 Broadway, New York, NY, United States, 10036
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
6.5 USDP/E ratio
–Dividend Yield
–Current Year
–
Last Year
–
Current Quarter
+727 000 USD
Last Quarter
+1 435 000 USD
Current Year
-222 000 USD
Last Year
-484 000 USD
Current Quarter
-788 000 USD
Last Quarter
-156 000 USD
Key Figures NUVB
1 year
3 years
5 years
10 years
EBITDA
-133 927 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-13.98 %
PEG Ratio
–
Return On Equity TTM
-95.54 %
Wall Street Target Price
6.5 USD
Revenue TTM
2 162 000 USD
Book Value
1.5 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
–
Dividend Yield
–
Gross Profit TTM
–
Earnings per share
-2.18 USD
Diluted Eps TTM
-2.18 USD
Most Recent Quarter
III 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics NUVB
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History NUVB
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation NUVB
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
199.5229
Price Sales TTM
448.3409
Enterprise Value EBITDA
2.2258
Price Book MRQ
1.9282
Financials NUVB
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators NUVB
For 52 weeks
1.21 USD
4.16 USD
50 Day MA
2.56 USD
Shares Short Prior Month
20 234 271
200 Day MA
2.73 USD
Short Ratio
5.79
Shares Short
9 970 011
Short Percent
4.19 %
BeatStart